top of page
reBalans wide.jpg

Introducing Re:Balans® 

a wearable device for hydration monitoring

Our Innovation Partners

This project has received funding from the European Union's Horizon 2020 research and development program under grant agreement No 969065.

EIC - LOGO 2021.png
InnoMed.png
Innovasjon-Norge-logo.png
AdolfØiensFond2.jpg
Eurostars_Circle-298x300_edited.png
InnoMed-logo.png
Eit Health.png
Regionale-Forskningsfond.png
Forskningsradet-logo.png
social_edited.jpg
Skjermbilde 2023-03-20 kl. 15.17_edited.jpg

This project has also received funding from the European Union's Horizon cybersecurity research and development program under grant agreement No 101094323 - NEMECYS, together with SINTEF.

Despite its importance in monitoring patients with fluid management conditions, identifying an effective approach continues to present a challenge in the field of medicine.
 

Re:Balans is currently only available for clinical investigations and research purposes, and are not yet cleared for medical use in the EU or US. 

​

“This technology represents the future of fluid monitoring”

Dr. Solfrid Romunstad, Chief Nephrologist (Helse Midt)

R&d.jpg

5 years of R&D 

The development of Re:Balans has been challenging and requires a dedicated team of developers, researchers, and over $10M in funding. Currently, we are in the process of seeking regulatory approval in US and Europe. 

​

Mode

DSC09158.JPG

Mode In Numbers

14

Employees

5

Years of dev

10M$

Capital invested

10+

Partners

CAREERS

We’re looking for innovative talent to join our team. See all positions and submit your CV.

Get in Touch

Thanks for submitting!

bottom of page